| 847591-62-2 Basic information More.. |
Product Name: | ICG-001 | Synonyms: | ICG-001;2H-Pyrazino[1,2-a]pyriMidine-1(6H)-carboxaMide, hexahydro-6-[(4-hydroxyphenyl)Methyl]-8-(1-naphthalenylMethyl)-4,7-dioxo-N-(phenylMethyl)-, (6S,9aS)-;ICG-1;(6S,9aS)-Hexahydro-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide;ICG-001/ICG001;(6S,9aS)-Hexahydro-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide ICG001;ICG 001, >=98%;ICG-001;ICG 001;ICG001 | CAS: | 847591-62-2 | MF: | C33H32N4O4 | MW: | 548.63158 | EINECS: | | Mol File: | 847591-62-2.mol | |
Use
(S,S)-ICG 001 is a β-turn peptidomimetic molecule inhibitor of β-catenin-Tcf-mediated transcription.
- ICG001
-
- US $38.00-131.00 / mg
- 2024-11-01
- CAS:847591-62-2
- Min. Order:
- Purity: 99.95%
- Supply Ability: 10g
- ICG-001
-
- US $1.00 / g
- 2019-12-24
- CAS:847591-62-2
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 20kg
|
847591-62-2
Recommend Suppliers |
|